Member Info for pomander

The money is tehre ? The budget's would barely cover the cost of a Mousetrap not even large enough to support 3 buses ! #Pheleftbehind

I think we all get that, just such a pity that Phe cannot produce it on a commercially viable basis. Anyway should be hearing shortly from teh Messiah on a number of things!

Yeep Bignose - totally agree.Project $1 billion US peak sales and no interest ?

I guess bunion, that should be taken care of by precribers on the back of the patient feedback data and directly via social media. My immediate concern is the lack of any other licenses being completed and particulalrly for the US, albeit on a conditional basis. Potential blockbuster - why no interest to get to the front of the queue ?

Elegance - you talk as if in a vacuum of the recent 85% share price collapse which was due to Luuzor failing to show meaningful statistical benefits over a placebo in the P3 trials. The �10m was riased back in January and no doubt largely on the back of expectations of much better P3 read outs. �10 m is also a tiny drop in the Ocean in comparison to the costs of getting a drug to market post FDA approval. There are always other pharma's looking at other pharma's , that's the nature of the industry - Teasers are sent out and and potential licensees pick up the phone but its pretty meaningless. It will have to be a partnership, licence or takeover at some point, IMM can not go to market alone,but it will not necessarily be on the sort of terms that you are expecting. You might also want to check out the foolkowing to get an idea of the headwinds that still lie ahead. Whilst I retain a small holding I am not counting any chickens on this one. BioMedTracker - Clinical Developmenet Success Rates for Investigational Drugs Pharma 2012*

No bitterness on my part- its all very entertaining and free. Hopefully I already a saved a number of punters some of their hard earned cash. They can always get back at about a quarter of the price- just think if you had followed n my advice you could buy back in now and have 4 x the number of shares you now hold, but that's always the problem when you fall in love and marry a share. I wonder why people tell others that they have filtered me and suggest that others to do the same - clearly the contents of my posts are just too valuable to miss out on ! oh and sorry no recommend from me - being called a horrible little troll is most upsetting !!!!!!!!!!!!!!

I should take with a very large pich of salt anything KA says, especially in reference to time frames - his record is absolutely appalling.

Has anyone lese noticed that Fortacin is back available on line at Chemists 4U at �99.99 for the 6.5ml, 20 dose can The Prime Doktor website, which I have never heard of before, alaso has it available but at �49.99 for the 5ml, 12 dose can. Seems a little odd that they are offering different can sizes. The Doctor 4 U site, no longer stocks it, only PE treatment is Priligy at �29.99 for 30 mg or 3 tablets seems alot more expensive than Fortacin, assuming one must be taken on a regular basis. The consultation questionnaire is also is also a far greater barrier to use than the Fortacin one which is easy peasy with no great warnings.. Wonder why its gone back on sale?

jabber - intrigued as to why you limit each one of your posts to one sentence and post multiple messages on the same topic- that's an awful lot of waste you are generating.

Mr Nige- thanks for the revelation but I think anyone with half a brain was already fully aware of the identity of the author. As I said the two of you are now working in concert in utter and complete desperation and with complete disregard to others in a vain attempt to rescue a most grotesque bloated position. You can all the meetings in the world but if Phe has nothing to deliver its a waste of everyone's time.

Yes, and the other one has got bells on it.

I guess the big question is- will a rescue deal be good for shareholders. IMI has a very weak hand.

Just to clear up the confusion for you Balman - Mr Nige does not have a meeting with his local MP. That was copied from Facebook, and not for the first time so clearly acting in concert to ramp this.

SOTRR- I am not based in UK so just make trips back as and when necessary, so If I can I will fly back. July/August I am traveling pretty much all the time. Sorry can not be more help- good luck

Waiting for sales/earnings is a lame excuse to hide behind particlalrly in regrad to pharma's which typically take some time before generating earnings. No one waited for Amazon, Google et al to generate earnings !

I am certainly negative about recent activity and the lack thereof. I originally believed that the ROW licensees had been put on ice by RP as part of my takeover theory but that now seems unlikely. My hope still rests on the disconnect between the volumes post UK launch and the reaction to later more significant events and of course recently. This may point to a stake having been built, although Bignose has elequently provoided a counter argument to this. Not sure how volume is 192k, when meant to be tradeable in lots of 10K , but not of any importance.

Well, well, volume of just 72,000 as I write, seems liquidity and interest must have both dried up altogether. Certainly no market expectation of further licensees or bouyant sales figures ( which I don't expect either as too early) which is a little worrying at this stage of the game. All very odd especially in context of post UK launch activity.

There is no infringement - they are acting in concert. #RUMBLED

Bignose- What does not add up for me is that RP/PLe's agent would presumably have pitched Fortacin to potential ROW licensees at the same time that it pitched it to Recordati, so well before the delays began to kick in. In any event, Fortacin has been launched since mid-feb and production issues resolved before that and yet no licensees concluded as yet so does not appear delays are the cause. If correct only 2 options 1) no interest 2) RP are holding back and 1) is looking more likely.

Newboy the fantasy filterer to the rescue- right on cue,